Literature DB >> 20231325

Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network.

Lori L Altshuler1, Ralph W Kupka, Gerhard Hellemann, Mark A Frye, Catherine A Sugar, Susan L McElroy, Willem A Nolen, Heinz Grunze, Gabriele S Leverich, Paul E Keck, Melanie Zermeno, Robert M Post, Trisha Suppes.   

Abstract

OBJECTIVE: The authors assessed gender differences in the proportion of clinical visits spent depressed, manic, or euthymic in patients with bipolar disorder.
METHOD: Data were analyzed from 711 patients with bipolar I or II disorder who were followed prospectively over 7 years (13,191 visits). The main outcome measures were the presence of symptoms of depression or of hypomania or mania, measured by the Inventory of Depressive Symptomatology and the Young Mania Rating Scale. Data were analyzed using three separate repeated-measures regressions with a logistic link function to model the probability that an individual was depressed, manic, or euthymic. The models controlled for bipolar I or bipolar II diagnosis, rapid cycling, age, time in the study, comorbid anxiety disorders, and comorbid substance use disorders.
RESULTS: In approximately half of visits, patients had depressive, manic, or hypomanic symptoms. The likelihood of having depressive symptoms was significantly greater for women than for men. This was accounted for by higher rates in women of rapid cycling and anxiety disorders, each of which was associated with increased rates of depression. All patient groups showed an increase in number of euthymic visits and a decrease in number of visits with depressive and manic symptoms with increased time in study.
CONCLUSIONS: Bipolar patients spend a substantial proportion of their time ill. Significant gender differences exist, with women spending a greater proportion of their visits in the depressive pole. This finding appears to be related to the corresponding differences in rates of rapid cycling and anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231325     DOI: 10.1176/appi.ajp.2009.09010105

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  25 in total

1.  Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.

Authors:  Francesco Benedetti; Sara Poletti; Daniele Radaelli; Clara Locatelli; Adele Pirovano; Cristina Lorenzi; Benedetta Vai; Irene Bollettini; Andrea Falini; Enrico Smeraldi; Cristina Colombo
Journal:  Psychopharmacology (Berl)       Date:  2014-10-28       Impact factor: 4.530

2.  Associated and mediating variables related to quality of life among service users with mental disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita
Journal:  Qual Life Res       Date:  2017-10-11       Impact factor: 4.147

3.  Peripheral zinc and neopterin concentrations are associated with mood severity in bipolar disorder in a gender-specific manner.

Authors:  Caitlin E Millett; Dahlia Mukherjee; Aubrey Reider; Adem Can; Maureen Groer; Dietmar Fuchs; Teodor T Postolache; Shannon L Kelleher; Erika F H Saunders
Journal:  Psychiatry Res       Date:  2017-05-17       Impact factor: 3.222

4.  Clinical features of bipolar disorder comorbid with anxiety disorders differ between men and women.

Authors:  Erika F H Saunders; Kate D Fitzgerald; Peng Zhang; Melvin G McInnis
Journal:  Depress Anxiety       Date:  2012-03-27       Impact factor: 6.505

5.  The effect of poor sleep quality on mood outcome differs between men and women: A longitudinal study of bipolar disorder.

Authors:  Erika F H Saunders; Julio Fernandez-Mendoza; Masoud Kamali; Shervin Assari; Melvin G McInnis
Journal:  J Affect Disord       Date:  2015-04-04       Impact factor: 4.839

6.  Progression of female reproductive stages associated with bipolar illness exacerbation.

Authors:  Wendy K Marsh; Terence A Ketter; Sybil L Crawford; Julia V Johnson; Aimee R Kroll-Desrosiers; Anthony J Rothschild
Journal:  Bipolar Disord       Date:  2012-05-31       Impact factor: 6.744

Review 7.  Impact of menstrual cycle events on bipolar disorder course: a narrative review of current evidence.

Authors:  Elena Aragno; Andrea Fagiolini; Alessandro Cuomo; Elena Paschetta; Giuseppe Maina; Gianluca Rosso
Journal:  Arch Womens Ment Health       Date:  2022-03-02       Impact factor: 3.633

8.  Gender differences in health-related quality of life in patients with bipolar disorder.

Authors:  Maria Syl D de la Cruz; Zongshan Lai; David E Goodrich; Amy M Kilbourne
Journal:  Arch Womens Ment Health       Date:  2013-04-16       Impact factor: 3.633

9.  Distinguishing bipolar from unipolar depression: the importance of clinical symptoms and illness features.

Authors:  A K Leonpacher; D Liebers; M Pirooznia; D Jancic; D F MacKinnon; F M Mondimore; B Schweizer; J B Potash; P P Zandi; F S Goes
Journal:  Psychol Med       Date:  2015-04-08       Impact factor: 7.723

10.  Asenapine in the Treatment of Bipolar Depression.

Authors:  Rif S El-Mallakh; Sharon Nuss; Dong Gao; Yonglin Gao; Surriya Colleen Ahmad; Clare Schrodt; Caleb Adler
Journal:  Psychopharmacol Bull       Date:  2020-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.